Radiotherapy Plus CAPOX, and Iparomlimab and Tuvonralimab (QL1706) as Neoadjuvant Therapy for LARC

Clinical trial NCT07291401 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07291401
Sponsor: Zhongnan Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Rectal Cancer Patients

Start date: 2026-01-01
Primary completion: 2027-01-01
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.